• The Alfred Mann Institute at the Technion (AMIT) supports the development and commercialization of biomedical innovations conceived by Technion researchers. Established in 2006 by the Technion and Dr. Alfred E. Mann, an American entrepreneur and philanthropist, the institute aspires to bridge the well-known gap between academic research and commercial success. AMIT currently manages four ventures, including Sealantis.

    For more details about AMIT go to www.amitechnion.com